All data are based on the daily closing price as of November 24, 2025
c

Chong Kun Dang Pharmaceutical

185750.KO
57.49 USD
-0.09
-0.16%

Overview

Last close
57.49 usd
Market cap
757.44M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
76.42 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.6686
Price/Book Value
1.1866
Enterprise Value
749.18M usd
EV/Revenue
0.6582
EV/EBITDA
2.7561

Key financials

Revenue TTM
1.14B usd
Gross Profit TTM
356.45M usd
EBITDA TTM
72.93M usd
Earnings per Share
N/A usd
Dividend
0.74 usd
Total assets
1.09B usd
Net debt
N/A usd

About

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    185750.KO
  • Exchange
    KO
  • Isin
    KR7185750007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Joo Kim
  • Headquarter
    Seoul
  • Web site
    https://www.ckdpharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top